Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

BACKGROUND: Fibrates have been reported to cause paradoxical decreases in HDL-C in certain patients. DESIGN AND METHODS: This post-hoc analysis explored the frequency/magnitude of HDL-C reductions in a pooled database of mixed dyslipidemic patients (LDL-C:3.4-5.7 mmol/L;TG:1.7-5.7 mmol/L) receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnier, Michel, Dong, Qian, Shah, Arvind, Johnson-Levonas, Amy O, Brudi, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250955/
https://www.ncbi.nlm.nih.gov/pubmed/22087637
http://dx.doi.org/10.1186/1476-511X-10-212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250955/
https://www.ncbi.nlm.nih.gov/pubmed/22087637
http://dx.doi.org/10.1186/1476-511X-10-212

Ejemplares similares